Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Chronic Pain and Mood Disorders
NCT06402019Completed
- Sponsor
- Benha University
- Start
- Mar 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in chronic pain and mood disorder (2 arms), sponsored by Benha University. Primary endpoint: Reduction of consumed analgesics at 6 months. Started Mar 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
chronic painmood disorder
Beyond the preview
Go deeper on NCT06402019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402019.